Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 284215, 13 pages
http://dx.doi.org/10.1155/2015/284215
Research Article

Mesenchymal Stem Cells from Patients with Rheumatoid Arthritis Display Impaired Function in Inhibiting Th17 Cells

1Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210008, China
2Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University, Nanjing, Jiangsu 210000, China

Received 24 December 2014; Revised 3 March 2015; Accepted 4 March 2015

Academic Editor: Ethan M. Shevach

Copyright © 2015 Yue Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Uccelli, L. Moretta, and V. Pistoia, “Mesenchymal stem cells in health and disease,” Nature Reviews Immunology, vol. 8, no. 9, pp. 726–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Shi, “Recent progress toward understanding the physiological function of bone marrow mesenchymal stem cells,” Immunology, vol. 136, no. 2, pp. 133–138, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Markides, O. Kehoe, R. H. Morris, and A. J. El Haj, “Whole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells—a rheumatoid arthritis mouse model,” Stem Cell Research and Therapy, vol. 4, no. 5, article 126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. I. B. McInnes and G. Schett, “Cytokines in the pathogenesis of rheumatoid arthritis,” Nature Reviews Immunology, vol. 7, no. 6, pp. 429–442, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Nakae, S. Saijo, R. Horai, K. Sudo, S. Mori, and Y. Iwakura, “IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 10, pp. 5986–5990, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. L. T. Nguyen, J. Jacobs, D. Mathis, and C. Benoist, “Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis,” Arthritis & Rheumatism, vol. 56, no. 2, pp. 509–520, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Liu, Q. Wu, D. Su et al., “A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis,” Arthritis Research & Therapy, vol. 14, no. 6, article R255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Liang, X. Li, H. Zhang et al., “Allogeneic mesenchymal stem cells transplantation in patients with refractory RA,” Clinical Rheumatology, vol. 31, no. 1, pp. 157–161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Ra, S. K. Kang, I. S. Shin et al., “Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells,” Journal of Translational Medicine, vol. 9, no. 1, p. 181, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Wang, X. Cong, G. Liu et al., “Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy,” Stem Cells and Development, vol. 22, no. 24, pp. 3192–3202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Krampera, S. Glennie, J. Dyson et al., “Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide,” Blood, vol. 101, no. 9, pp. 3722–3729, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Di Ianni, B. Del Papa, M. De Ioanni et al., “Mesenchymal cells recruit and regulate T regulatory cells,” Experimental Hematology, vol. 36, no. 3, pp. 309–318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Ghannam, J. Pène, G. Torcy-Moquet, C. Jorgensen, and H. Yssel, “Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype,” Journal of Immunology, vol. 185, no. 1, pp. 302–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Jorgensen, “Mesenchymal stem cells in arthritis: role of bone marrow microenvironment,” Arthritis Research & Therapy, vol. 12, no. 4, article 135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis & Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Publisher · View at Google Scholar · View at Scopus
  17. M. M. Duffy, J. Pindjakova, S. A. Hanley et al., “Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor,” European Journal of Immunology, vol. 41, no. 10, pp. 2840–2851, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Tatara, K. Ozaki, Y. Kikuchi et al., “Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation,” Cytotherapy, vol. 13, no. 6, pp. 686–694, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Rafei, P. M. Campeau, A. Aguilar-Mahecha et al., “Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner,” Journal of Immunology, vol. 182, no. 10, pp. 5994–6002, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T.-L. Yew, F.-Y. Chiu, C.-C. Tsai et al., “Knockdown of p21Cip1/Waf1 enhances proliferation, the expression of stemness markers, and osteogenic potential in human mesenchymal stem cells,” Aging Cell, vol. 10, no. 2, pp. 349–361, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Y. Hui, J. A. Meens, C. Schick et al., “Src and FAK mediate cell-matrix adhesion-dependent activation of met during transformation of breast epithelial cells,” Journal of Cellular Biochemistry, vol. 107, no. 6, pp. 1168–1181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Zhao, D. G. Phinney, D. Bonnet, M. Dominici, and M. Krampera, “Mesenchymal stem cell biodistribution, migration, and homing in vivo,” Stem Cells International, vol. 2014, Article ID 292109, 2 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H. A. Papadaki, H. D. Kritikos, C. Gemetzi et al., “Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect,” Blood, vol. 99, no. 5, pp. 1610–1619, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. T. Mohanty, L. Kottam, A. Gambardella et al., “Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis,” Arthritis Research & Therapy, vol. 12, no. 4, article R149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Djouad, V. Fritz, F. Apparailly et al., “Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen-induced arthritis,” Arthritis & Rheumatism, vol. 52, no. 5, pp. 1595–1603, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Sullivan, J. M. Murphy, M. D. Griffin et al., “Genetic mismatch affects the immunosuppressive properties of mesenchymal stem cells in vitro and their ability to influence the course of collagen-induced arthritis,” Arthritis Research & Therapy, vol. 14, no. 4, article R167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Xu, D. Wang, D. Liu et al., “Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome,” Blood, vol. 120, no. 15, pp. 3142–3151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Bocelli-Tyndall, L. Bracci, G. Spagnoli et al., “Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro,” Rheumatology, vol. 46, no. 3, pp. 403–408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Larghero, D. Farge, A. Braccini et al., “Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 67, no. 4, pp. 443–449, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Wang, X. Feng, L. Lu et al., “A CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus,” Arthritis & Rheumatology, vol. 66, no. 8, pp. 2234–2245, 2014. View at Publisher · View at Google Scholar
  31. L. A. Tesmer, S. K. Lundy, S. Sarkar, and D. A. Fox, “Th17 cells in human disease,” Immunological Reviews, vol. 223, no. 1, pp. 87–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Yang, Y. Liu, P. Kelk et al., “A subset of IL-17+ mesenchymal stem cells possesses anti-Candida albicans effect,” Cell Research, vol. 23, no. 1, pp. 107–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. M. M. Duffy, T. Ritter, R. Ceredig, and M. D. Griffin, “Mesenchymal stem cell effects on T-cell effector pathways,” Stem Cell Research & Therapy, vol. 2, no. 4, article 34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Li, G. Ren, Y. Huang et al., “Mesenchymal stem cells: a double-edged sword in regulating immune responses,” Cell Death and Differentiation, vol. 19, no. 9, pp. 1505–1513, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. L. Gartel and S. K. Radhakrishnan, “Lost in transcription: p21 repression, mechanisms, and consequences,” Cancer Research, vol. 65, no. 10, pp. 3980–3985, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M.-C. Kastrinaki, P. Sidiropoulos, S. Roche et al., “Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 67, no. 6, pp. 741–749, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Wolfenson, A. Bershadsky, Y. I. Henis, and B. Geiger, “Actomyosin-generated tension controls the molecular kinetics of focal adhesions,” Journal of Cell Science, vol. 124, no. 9, pp. 1425–1432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-M. Tang, J.-N. Wang, L. Zhang et al., “VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart,” Cardiovascular Research, vol. 91, no. 3, pp. 402–411, 2011. View at Publisher · View at Google Scholar · View at Scopus